455:
25:
83:
545:
256:
394:"Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis"
515:
270:
298:
InChI=1S/C17H15Cl2N5O5/c1-7(2)9-6-12(22-24(3)16(9)26)28-13-10(18)4-8(5-11(13)19)20-15(25)14-21-17(27)29-23-14/h4-7H,1-3H3,(H,20,25)(H,21,23,27)
496:
321:
290:
119:
95:
540:
550:
489:
177:
520:
530:
525:
482:
535:
431:
413:
374:
421:
405:
364:
354:
193:
35:
426:
393:
466:
369:
342:
157:
509:
462:
317:
359:
54:
232:
417:
409:
44:
435:
378:
24:
454:
74:
143:
343:"Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH"
168:
82:
546:
Experimental drugs developed for non-alcoholic fatty liver disease
255:
246:
18:
341:
Finan, Brian; Parlee, Sebastian D.; Yang, Bin (April 2021).
278:
CC(C)C1=CC(=NN(C1=O)C)OC2=C(C=C(C=C2Cl)NC(=O)C3=NOC(=O)N3)Cl
470:
49:
39:
244:
231:
192:
187:
167:
142:
110:
94:
89:
320:drug that is being developed for the treatment of
156:
490:
8:
73:
497:
483:
81:
425:
368:
358:
333:
295:
275:
124:
516:Thyroid hormone receptor beta agonists
72:
392:Karim, Gres; Bansal, Meena B (2023).
176:
7:
451:
449:
147:
14:
322:non-alcoholic fatty liver disease
453:
216:
210:
204:
23:
303:Key:WFIWVDVCNWOMQV-UHFFFAOYSA-N
134:-1,2,4-oxadiazole-3-carboxamide
222:
198:
1:
398:TouchREVIEWS in Endocrinology
469:. You can help Knowledge by
360:10.1016/j.molmet.2020.101153
567:
448:
188:Chemical and physical data
286:
266:
115:
80:
410:10.17925/EE.2023.19.1.60
38:, as no other articles
465:-related article is a
347:Molecular Metabolism
541:Isopropyl compounds
77:
551:Pharmacology stubs
57:for suggestions.
47:to this page from
478:
477:
311:
310:
257:Interactive image
71:
70:
16:Chemical compound
558:
499:
492:
485:
457:
450:
440:
439:
429:
389:
383:
382:
372:
362:
338:
259:
239:
224:
218:
212:
206:
200:
180:
160:
150:
149:
85:
78:
76:
66:
63:
52:
50:related articles
27:
19:
566:
565:
561:
560:
559:
557:
556:
555:
506:
505:
504:
503:
446:
444:
443:
391:
390:
386:
340:
339:
335:
330:
316:is a selective
307:
304:
299:
294:
293:
282:
279:
274:
273:
262:
237:
227:
221:
215:
209:
203:
183:
163:
146:
138:
135:
123:
122:
106:
103:Investigational
67:
61:
58:
48:
45:introduce links
28:
17:
12:
11:
5:
564:
562:
554:
553:
548:
543:
538:
533:
528:
523:
518:
508:
507:
502:
501:
494:
487:
479:
476:
475:
458:
442:
441:
384:
332:
331:
329:
326:
309:
308:
306:
305:
302:
300:
297:
289:
288:
287:
284:
283:
281:
280:
277:
269:
268:
267:
264:
263:
261:
260:
252:
250:
242:
241:
235:
229:
228:
225:
219:
213:
207:
201:
196:
190:
189:
185:
184:
182:
181:
173:
171:
165:
164:
162:
161:
153:
151:
140:
139:
137:
136:
126:
118:
117:
116:
113:
112:
108:
107:
105:
104:
100:
98:
92:
91:
87:
86:
69:
68:
62:September 2023
55:Find link tool
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
563:
552:
549:
547:
544:
542:
539:
537:
534:
532:
529:
527:
524:
522:
519:
517:
514:
513:
511:
500:
495:
493:
488:
486:
481:
480:
474:
472:
468:
464:
459:
456:
452:
447:
437:
433:
428:
423:
419:
415:
411:
407:
403:
399:
395:
388:
385:
380:
376:
371:
366:
361:
356:
352:
348:
344:
337:
334:
327:
325:
323:
319:
315:
301:
296:
292:
285:
276:
272:
265:
258:
254:
253:
251:
248:
243:
236:
234:
230:
197:
195:
191:
186:
179:
178:ChEMBL4782668
175:
174:
172:
170:
166:
159:
155:
154:
152:
145:
141:
133:
129:
125:
121:
114:
109:
102:
101:
99:
97:
93:
88:
84:
79:
65:
56:
51:
46:
42:
41:
37:
32:This article
30:
26:
21:
20:
521:Chloroarenes
471:expanding it
463:pharmacology
460:
445:
404:(1): 60–70.
401:
397:
387:
350:
346:
336:
318:thyromimetic
313:
312:
131:
127:
96:Legal status
90:Legal status
59:
33:
531:Pyridazines
526:Oxadiazoles
240: g·mol
111:Identifiers
510:Categories
353:: 101153.
328:References
245:3D model (
233:Molar mass
120:IUPAC name
53:; try the
40:link to it
418:2752-5457
158:146402726
130:--5-oxo-4
43:. Please
536:Anilides
436:37313239
427:10258622
379:33359400
314:TERN-501
75:TERN-501
370:8085542
194:Formula
144:PubChem
434:
424:
416:
377:
367:
271:SMILES
238:440.24
169:ChEMBL
36:orphan
34:is an
461:This
291:InChI
247:JSmol
467:stub
432:PMID
414:ISSN
375:PMID
422:PMC
406:doi
365:PMC
355:doi
148:CID
512::
430:.
420:.
412:.
402:19
400:.
396:.
373:.
363:.
351:46
349:.
345:.
324:.
211:Cl
208:15
202:17
498:e
491:t
484:v
473:.
438:.
408::
381:.
357::
249:)
226:5
223:O
220:5
217:N
214:2
205:H
199:C
132:H
128:N
64:)
60:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
